BLRX
BioLineRx·NASDAQ
--
--(--)
--
--(--)
4.50 / 10
Netural
Capital flow assessment yields 7.45/10, denoting robust fund flow characteristics. Strengths in Small and Large trends confront pressures from overall, block, Medium, and Extra-large patterns, resulting in positive liquidity outlook. Analyst sentiment reflects overwhelmingly bullish analyst consensus with strong conviction. The rating profile includes Strong Buy(100.0%) from 3 analytical reports, supported by 1.54 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-06-17
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate33.3%
Is money flowing into or out of BLRX?
- BLRX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.50/10 (Netural).
